Northwestern Mutual Wealth Management CO Dynavax Technologies Corp Transaction History

Northwestern Mutual Wealth Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $257 - $329	22 New	22 $0
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $2,462 - $3,292	250 Added 250.0%	350 $4,000
Q1 2023 May 15, 2023	BUY	$9.44 - $11.88 $944 - $1,188	100 New	100 $0
Q2 2022 Aug 04, 2022	SELL	$7.45 - $12.83 $81 - $141	-11 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$9.75 - $14.44 $107 - $158	11 New	11 $0
Q2 2021 Aug 13, 2021	SELL	$7.25 - $10.99 $311 - $472	-43 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.57 - $11.18 $196 - $480	43 New	43 $0

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.